As of September 1, 2022 8:00pm ET
About this ETF
The investment seeks to provide investment results that, before fees
and expenses, correspond generally to the total return performance of
the Innovation Labs Cannabis Index.The fund will invest at least 80% of
its total assets in the component securities of the index. It will also
invest, under normal circumstances, at least 80% of its net assets, plus
borrowings for investment purposes, in exchange listed common stock (or
corresponding American Depositary Receipts ("ADRs") of Cannabis
Companies. The index is a proprietary, rules-based index designed to
track the performance of a portfolio of Cannabis Companies. The fund is
non-diversified.
Trailing Total Returns
Inception Date: July 09, 2019
Performance Details
Total
return reflects performance without adjusting for sales charges or the
effects of taxation, but is adjusted to reflect all actual ongoing fund
expenses and assumes reinvestment of dividends and capital gains. If
adjusted, sales charges would reduce the performance quoted. Performance
data quoted represents past performance, is no guarantee of future
results, and may not provide an adequate basis for evaluating the
performance potential of the product over varying market conditions or
economic cycles. Current performance may be higher or lower than the
performance data quotes. The investment return and principal value of an
investment will fluctuate so that an investor's shares, when redeemed,
may be worth more or less than their original cost. Standardized Returns
Inception Date: July 09, 2019
|
Morningstar Wrap-Up
Morningstar Style Box
Value
Blend
Growth
Large
Medium
Small
As of 07/29/2022 Risk:
|
No comments:
Post a Comment